Ó³»­´«Ã½

Ó³»­´«Ã½ researchers Matthew Meyerson and Heidi Greulich describe how they and Bayer scientists developed the first FDA-approved cancer drug to come from a Ó³»­´«Ã½ scientific discovery.

In vivo CRISPR screens identify genes that improve persistence and function of CAR-T cells in a model of cancer

Tamoxifen encourages uterine cell growth in mice without causing mutations; findings could change how some breast cancers are treated in the future

Test of circulating tumor cells offers less invasive option for multiple myeloma surveillance, staging, and biological study compared to bone marrow biopsies

The BrightSeq clinical research and testing initiative aimed at bringing liquid biopsy and genomic technologies into routine clinical care.

Findings suggest that previously-approved precision medicines may benefit children with certain childhood brain tumors.

Mutation-based score provides a personalized indicator of disease severity and progression risk, could help inform early intervention strategies

Wolu Chukwu talks about how she brings a community-first focus to her work in cancer genetics. 

Exploiting "viral mimicry," mIDH1 inhibitors trick tumors into thinking they are infected with a virus.

Bill Sellers, head of Ó³»­´«Ã½â€™s Cancer Program, talks about how to discover new classes of genetic dependencies that could move therapies closer to curing cancer patients.